ADENOCARCINOMA

Clinical trials for ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 6 Completed 5 Terminated 3

New vaccine combo aims to halt prostate cancer growth without surgery

Disease control Not yet recruiting

This phase 2 trial tests a combination of a vaccine (TriAdeno) and an immune-boosting drug (N-803) in 52 men with early-stage, low- or medium-risk prostate cancer who are currently on active surveillance. The vaccine targets three proteins found in prostate cancer cells, while N-…

Matched conditions: ADENOCARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 02, 2026 02:00 UTC

ADENOCARCINOMA

Get alerted when new ADENOCARCINOMA trials appear

New vaccine combo aims to halt prostate cancer growth without surgery